Commentary

Podcast

Managed Care Cast Presents: Navigating Burdens and Treatment Challenges of IPF

A trio of experts discuss the importance of early diagnosis, treatment barriers, and therapies in the pipeline for idiopathic pulmonary fibrosis (IPF).

Today we are bringing you insights from 3 separate interviews with experts about the treatment, management, and burdens of idiopathic pulmonary fibrosis (IPF).

In this podcast, you’ll hear insight from the following individuals:

  • Toby Maher, MD, PhD, professor of clinical medicine, Keck School of Medicine, University of Southern California
  • Martin Kolb, MD, PhD, professor of medicine, McMaster University
  • Steven Nathan, MD, FCCP, medical director of the Advanced Lung Disease Program and Lung Transplant Program, Inova Fairfax Hospital, and professor of medicine, University of Virginia

These experts discuss what IPF is, how it impacts patients’ quality of life, barriers to care, and treatments in the pipeline.

Listen above or through one of these podcast services:

iTunes
TuneIn
Stitcher
Spotify

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Mansi Shah, MD
CK Wang, MD, COTA
Screenshot of Ivo Abraham, PhD, RN, during a video interview
Gordon Crofoot, MD, PA
David Awad, PharmD, BCOP
Merrill H. Stewart, MD
Andrew Evens, DO, MBA, MSc, deputy director for clinical services and chief physician officer, Rutgers Cancer Institute and Jack & Sheryl Morris Cancer Center
Hamlet Gasoyan, PhD
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo